Pharmaceutical Patent Expert Opines on Commercial Licensing Dispute

This case involves a commercial dispute between two major pharmaceutical companies with regard to a patent license. An expert with career experience in licensing databases and other public resources was sought to comment on licensing practices in the pharmaceutical industry.

Question(s) For Expert Witness

1. Please briefly describe your work as it relates to patent licensing in the pharmaceutical industry.

Expert Witness Response E-113877

I have been involved in pharmaceutical patent, technology, and product licensing activities as both a pharmaceutical business development executive, in-house legal counsel, and independent consultant for more than 25 years. I have been involved in drafting and negotiating commercial and patent license agreements in numerous deals involving major pharmaceutical companies, development stage companies, and academic institutions during that time. I have worked for a major pharmaceutical company, and have consulted with and served on the board of directors of a number of smaller, development stage companies, both public and private - domestic and foreign. I have been called upon once as an expert witness on a prior patent licensing dispute involving a major pharmaceutical company and a major academic institution. I was asked to provide my opinion on the typical and most reasonable interpretation of some common licensing provisions in the agreement at issue. I provided extensive written evaluation and interpretation of many common licensing provisions that were in dispute.